Efficacy of the Mentha crispa in the treatment of women with Trichomonas vaginalis infection

Archives of Gynecology and Obstetrics

Volumn 286, Issue 1, 2012, Pages 125-130

  Moraes, Maria Elisabete A ^a   Cunha, Gilmara H ^a   Bezerra, Mirna M ^a   Fechine, Francisco V ^a   Pontes, Andréa V ^a   Andrade, Wanda S ^a   Bezerra, Fernando A Frota ^a   Moraes, Manoel O ^a   Cavalcanti, Pacífica P ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Clinical trial; Phytotherapy; Sexually transmitted diseases; Trichomonas vaginalis

Indexed keywords

ANTIPARASITIC AGENT; GIAMEBIL; SECNIDAL; SECNIDAZOLE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BURNING SENSATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DYSPAREUNIA; DYSURIA; EPIGASTRIC PAIN; FEMALE; HUMAN; LAMIACEAE; MAJOR CLINICAL STUDY; MALODOROUS VAGINAL SECRETION; METALLIC TASTE; NAUSEA; PELVIS PAIN SYNDROME; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SPEARMINT; TASTE DISORDER; TRICHOMONIASIS; UNPLEASANT ODOR IN THE URINE; VAGINA DISCHARGE; VOMITING;

ADULT; ANTITRICHOMONAL AGENTS; DOUBLE-BLIND METHOD; DYSPAREUNIA; DYSURIA; FEMALE; HUMANS; MALE; MENTHA; METRONIDAZOLE; MIDDLE AGED; NAUSEA; PELVIC PAIN; PHYTOTHERAPY; PLANT EXTRACTS; PRURITUS; STATISTICS, NONPARAMETRIC; TASTE DISORDERS; TRICHOMONAS VAGINALIS; TRICHOMONAS VAGINITIS; VAGINAL DISCHARGE; YOUNG ADULT;

EID: 84864445274     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-012-2251-4     Document Type: Article

References (28)

1. Domeika M, Zhurauskaya L, Savicheva A, Frigo N, Sokolovskiy E, Hallén A, Unemo M, Ballard RC (2010) Guidelines for the laboratory diagnosis of trichomoniasis in East European countries. J Eur Acad Dermatol Venereol 24:1-10
2. Kissinger P, Amedee A, Clark RA, Dumestre J, Theall KP, Myers L, Hagensee ME, Farley TA, Martin DH (2009) Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex Transm Dis 36:11-16
3. Mann JR, McDermott S, Barnes TL, Hardin J, Bao H, Zhou L (2009) Trichomoniasis in pregnancy and mental retardation in children. Ann Epidemiol 19:891-899
4. Depuydt CE, Leuridan E, Damme PV, Bogers J, Vereecken AJ, Donders GGG (2010) Epidemiology of Trichomonas vaginalis and Human Papillomavirus infection detected by real-time PCR in flanders. Gynecol Obstet Invest 70:273-280
5. Hardman JG, Limbird LE, Gilman AG (2005) Goodman and Gilman's the pharmacological basis of therapeutics. McGraw-Hill, New York
6. Soper D (2004) Trichomoniasis: under control or undercon-trolled? Am J Obstet Gynecol 190:281-290
7. Gillis JC, Wiseman LR (1996) Secnidazole: a review of its antimicrobial activity, pharmacokinetic properties and therapeutic use in the management of protozoal infections and bacterial vaginosis. Drugs 51:621-638
8. Cunha GH, Fechine FV, Santos LKX, Pontes AVP, Oliveira JC, Moraes MO, Bezerra FAF, Moraes MEA (2011) Efficacy of the tincture of jalapa in the treatment of functional constipation: a double-blind, randomized, placebo-controlled study. Contemp Clin Trials 32:153-159
9. Terauchi M, Hiramitsu S, Akiyoshi M, Owa Y, Kato K, Obayashi S, Matsushima E, Kubota T (2011) Effects of three Kampo formulae: Tokishakuyakusan (TJ-23), Kamishoyosan (TJ-24), and Keishi-bukuryogan (TJ-25) on Japanese peri- and postmenopausal women with sleep disturbances. Arch Gynecol Obstet 284:913-921
10. Teles NSB, Fechine FV, Viana FAC, Viana IOL, Nascimento DF, Leite ALAS, Frota Bezerra FA, Moraes MO, Moraes MEA (2011) Evaluation of the therapeutic efficacy of Mentha crispa in the treatment of giardiasis. Contemp Clin Trials 32:809-813
11. Dimech GS, Gonçalves ES, Araújo AV, Arruda VM, Baratella-Evêncio L, Wanderley AG (2006) Evaluation of the hydroalco-holic extract of Mentha crispa on the reproductive performance in Wistar rats. Braz J Pharmacogn 16:152-157
12. Drugs for sexually transmitted infections. Treat Guidel Med Lett 95:53-60. http://secure.medicalletter.org/TG-article-95a. Accessed 14 June 2011
13. Santana CF, Almeida ER, Santos ER, Souza IA (1992) Action of Mentha crispa hydroethanolic extract in patients bearing intestinal protozoan. Fitoterapia 63:409-410
14. Leon SR, Konda KA, Bernstein KT, Pajuelo JB, Rosasco AM, Caceres CF, Coates TJ, Klausner JD (2009) Trichomonas vaginalis infection and associated risk factors in a socially-marginalized female population in coastal Peru. Infect Dis Obstet Gynecol. doi:10.1155/2009/752437
15. Hilber AM, Francis SC, Chersich M, Scott P, Redmond S, Bender N, Miotti P, Temmerman M, Low N (2010) Intravaginal practices, vaginal infections and HIV acquisition: systematic review and meta-analysis. PLoS ONE 5:1-11
16. Swygard H, Seña AC, Hobbs MM, Cohen MS (2004) Tricho-moniasis: clinical manifestations, diagnosis and management. Sex Transm Dis 80:91-95
17. Fichorova RN (2009) Impact of T. vaginalis infection on innate immune responses and reproductive outcome. J Reprod Immunol 83:185-189
18. Gülmezoglu AM (2007) Interventions for trichomoniasis in pregnancy (review). Cochrane Collab 4:1-9
19. Chersich MF, Rees HV (2008) Vulnerability of women in southern Africa to infection with HIV: biological determinants and priority health sector interventions. AIDS 22:27-40
20. Schneider H, Coetzee DJ, Fehler HG, Bellingan A, Dangor Y, Radebe F, Ballard RC (1998) Screening for sexually transmitted diseases in rural South African women. Sex Transm Dis 74:147-152
21. Moodley P, Connolly C, Sturm W (2002) Interrelationships among HIV type 1 infection, bacterial vaginosis, trichomoniasis and the presence of yeasts. J Infect Dis 185:69-73
22. Brabin L (2001) Hormonal markers of susceptibility to sexually transmitted infections: Are we taking them seriously? BMJ 323:394-395
23. Baeten JM, Nyange PM, Richardson BA, Lavreys L, Chohan B, Martin HL Jr, Mandaliya K, Ndinya-Achola JO, Bwayo JJ, Kreiss JK (2001) Hormonal contraception and risk of sexually transmitted disease acquisition: Results from a prospective study. Am J Obstet Gynecol 185:380-385
24. Morrison CS, Bright P, Wong EL, Kwok C, Yacobson I, Gaydos CA, Tucker HT, Blumenthal PD (2004) Hormonal contraceptive use, cervical ectopy, and the acquisition of cervical infections. Sex Transm Dis 31:561-567
25. Mohllajee AP, Curtis KM, Martins SL, Peterson HB (2006) Hormonal contraceptive use and risk of sexually transmitted infections: a systematic review. Contraception 73:154-165
26. Vera EG, Orozco HH, Soto SS, Aburto EL (2008) Condom effectiveness to prevent sexually transmitted diseases. Ginecol Obstet Mex 76:88-96
27. Buitrón GFR, Gonzalo BLF, Oropez RG, Romero-Cabello R (1997) Comparative study for the evaluation of the efficacy and safety of metronidazole and secnidazole in the treatment of vaginal trichomoniasis. Ginecol Obstet Mex 65:487-491
28. Bohbot JM, Vicaut E, Fagnen D, Brauman M (2010) Treatment of bacterial vaginosis: a multicenter, double-blind, doubly-dummy, randomized phase III study comparing secnidazole and metronida-zole. Infect Dis Obstet Gynecol. doi:10.1155/2010/705692